Clinical Trials Sponsored by Affinium Pharmaceuticals, Ltd

Total 4431 results

Xi'An Aolitai Pharmaceutical Technology Co Ltd

Recruiting

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

Drug-Induced Liver Injury | Cholestatic Liver Injury | Mixed Liver Injury

China
Jae Myung Park
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients (NSAID)

Osteoarthritis
Jung Im Jung
Taejoon Pharmaceutical Co., Ltd.

Recruiting

Chest CT Using Low-concentration Iodine Contrast Media

Pulmonary Disease

Korea, Republic of
Asan Medical Center
Korean Cancer Study Group; Boryung Pharmaceutical Co., Ltd

Recruiting

A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer (BRISK)

Advanced Solid Tumors | Metastatic Cancer | Solid Tumors

Korea, Republic of
Sun Yat-sen University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma (ALTER-HN005)

Nasopharyngeal Neoplasms
Beijing Tiantan Hospital
Tasly Pharmaceutical Group Co., Ltd; Beijing Neurosurgical Institute

Recruiting

Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

Recurrent Glioblastoma

China
Peking Union Medical College Hospital
CSPC Ouyi Pharmaceutical Group Co., Ltd.

Not yet recruiting

Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis

Cryptococcal Meningitis

China
The Affiliated Hospital of Qingdao University
Changzhou Pharmaceutical Factory Co., Ltd

Not yet recruiting

Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

Pharmacokinetics | Safety
Second Affiliated Hospital of Nanchang University
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Not yet recruiting

Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis (ATTRACT)

NSCLC | EGFR Activating Mutation | Leptomeningeal Metastasis

China
Sun Yat-sen University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma

China
Huazhong University of Science and Technology
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

Gastric Cancer

China
The Affiliated Hospital of Qingdao University
Wenzhou Haihe Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Eldecalcitol Soft Capsule in Healthy Chinese Subjects

Healthy

China
Huazhong University of Science and Technology
CSPC Ouyi Pharmaceutical Co., Ltd.

Unknown

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Biliary Tract Cancer

China
First Affiliated Hospital of Zhejiang University
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets

Improvement of Pruritus in Hemodialysis Patients

China
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

China
Encube Ethicals Pvt. Ltd.
Novum Pharmaceutical Research Services; ACM Global Laboratories

Completed

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis

Tinea Pedis

United States, Belize, Saint Lucia
Seung-Jung Park
CardioVascular Research Foundation, Korea; Boryung Pharmaceutical Co., Ltd

Terminated

Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)

Coronary Artery Disease

Korea, Republic of
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Completed

A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Chulalongkorn University
The Kidney Foundation of Thailand; Siam Pharmaceutical Co Ltd

Completed

Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

Peritoneal Dialysis Associated Peritonitis

Thailand
Qilu Pharmaceutical Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital

Unknown

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Simcere Pharmaceutical Co., Ltd

Unknown

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

T Cell Lymphoma

China
Peking University People's Hospital
Monash University; Beijing ShuangLu Pharmaceutical Co., Ltd.

Unknown

A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Jong Woo Chung
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

A Study on the Effect of Cilostazol in Patients With Chronic Tinnitus (CITI-ESR)

Tinnitus

Korea, Republic of
Jiangsu Simcere Pharmaceutical Co., Ltd.
The First People's Hospital of Lianyungang

Unknown

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Esophageal Cancer

China
Taipei Medical University WanFang Hospital
Sheng Pu Pharmaceutics Co., Ltd.

Unknown

S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease

Liver Diseases

Taiwan
Tianjin Medical University Eye Hospital
Abbvie Pharmaceutical Trading (Shanghai) Co., Ltd.

Recruiting

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

Diabetic Macular Edema | Pars Plana Vitrectomy | Dexamethasone Intravitreal Implant | Intraoperative Optical Coherence Tomography

China
Jinling hospital Nanjing, Jiangsu, China
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Recruiting

A Study of TH-SC01 in the Treatment of Radiation-induced Rectal Injury

Rectal Injury

China
Xiangya Hospital of Central South University
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke (EARLYS)

Ischemic Stroke, Acute | Treatment Outcome

China
Nanfang Hospital of Southern Medical University
Jiangsu Simcere Pharmaceutical Co., Ltd.

Not yet recruiting

Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis
Peking Union Medical College Hospital
Yichang Humanwell Pharmaceutical Co., Ltd., China

Not yet recruiting

The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients

Postoperative Pain | Analgesia
Takayuki Yoshino
Ono Pharmaceutical Co. Ltd

Recruiting

Study to Nivolumab Following Preoperative Chemoradiotherapy

Cancer of Rectum

Japan
First Affiliated Hospital of Zhejiang University
Hangzhou HeZheng Pharmaceutical Co., Ltd

Unknown

Study of the Safety, Tolerability and Pharmacokinetics of HZ-A-018 in Patients With B Cell Lymphoma

Lymphoma, B-Cell

China
Sichuan Baili Pharmaceutical Co., Ltd.
Peking University First Hospital; Beijing Hospital

Unknown

Post-marketing Registration Study of Nifekalant Hydrochloride (NIF) Injection

Ventricular Fibrillation | Ventricular Tachycardia

China
First Affiliated Hospital of Zhejiang University
Guangdong Kangda Pharmaceutical Co., Ltd

Unknown

Study to Evaluate the Tolerance and Pharmacokinetics of Suramin Sodium

Hand, Foot and Mouth Disease

China
Henan Provincial People's Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC (ALTER-L025)

Non-squamous Cell Non-Small Cell Lung Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
Second Hospital of Shanxi Medical University

Completed

A Pilot Bioequivalence Study of Pomalidomide

Bioequivalence

China
First Affiliated Hospital of Zhejiang University
Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Completed

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)

Safety Issues
Peking University Third Hospital
Peking University; Shanghai Greenvalley Pharmaceutical Co., Ltd.

Completed

Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study

Adverse Drug Reaction

China
Boryung Pharmaceutical Co., Ltd
Kyunghee university hospital A Drug Analytical Laboratory

Completed

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

Hypertension

Korea, Republic of
The First Affiliated Hospital of Soochow University
Xian-Janssen Pharmaceutical Ltd.

Unknown

Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Myelodysplastic Syndromes | Acute Myelocytic Leukemia

China
Jun Cheng
Sanofi; Fujian Cosunter Pharmaceutical Co. Ltd

Unknown

Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients

Chronic Hepatitis B

China
The First Hospital of Jilin University
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

Diffuse Large B-cell Lymphoma

China
Nanfang Hospital of Southern Medical University
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients (PANORAMA)

Chemotherapy | Immunotherapy

China
Peking University People's Hospital
Beijing Qingyi Taike Pharmaceutical Technology Co., Ltd

Not yet recruiting

LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia
Qu Yiqing
Qilu Pharmaceutical Co., Ltd.

Recruiting

Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Pulmonary Disease, Chronic Obstructive

China
Henan Cancer Hospital
Rongchang Biopharmaceutical; Zhengda Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer

HER2-positive Gastric Cancer | Advanced Gastric Carcinoma

China
Jiangxi Provincial Cancer Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (ALTER-E005)

Digestive System Diseases | Gastrointestinal Diseases | Neoplasms by Histologic Type | Neoplasms by Site | Gastrointestinal Neoplasms | Digestive System Neoplasms | Carcinoma, Squamous Cell | Esophageal Neoplasms | Esophageal Diseases | Neoplasms, Squamous Cell | Esophageal Squamous Cell Carcinoma

China
Guangzhou Sinogen Pharmaceutical Co., Ltd
Parexel; ClinChoice Enterprise Management (Shanghai) Limited

Recruiting

Study of SGN1 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

United States, China
The Central Hospital of Lishui City
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

Nephrogenic Fibrosing Dermopathy

China
Southern California University of Health Sciences
Sun Ten Pharmaceutical Co Ltd.

Completed

Effects of Lagenbone on Bone Mineral Density

Osteoporosis

United States

Clinical Trials Sponsored by Affinium Pharmaceuticals, Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations